Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV special focuses on the drugs.

THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

Semaglutide mimics the action of the natural protein glucagon-like peptide 1(GLP-1), a hormone from a family of chemical messengers called the incretins, which Belgian physiologist Jean LaBarre ...

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

GLP-1 (Glucagon-Like Peptide-1) analogues are synthetic drugs designed to mimic the action of the naturally occurring GLP-1 hormone, which plays a critical role in glucose metabolism. These analogues ...

Amycretin, works slightly differently from Novo’s blockbuster weight-loss drug Wegovy, which mimics the GLP-1 hormone to address feelings of hunger and manage sugar levels. Wegovy has the same active ...